BioLive Seoul

The BioLive Korea is an international trade fair for biotechnological developments and services of the pharmaceutical industry. The biotechnology sector of the pharmaceutical industry is becoming increasingly important. Issues such as genetic engineering, genetically modified products but also stem cell therapy, population genetics and transplantation are increasingly dealing with the market. From the companies who want to stay and expand in the market, it will be required that they go along on this point with market developments. Korea is already working here on a very high level. Nevertheless, it is essential to follow the trend and the latest technologies, because this is the only way to guarantee international competitors ability at the rapidly changing market structure. For this reason, taking part in the BioLive Korea, the communication and information platform for biopharmaceutical companies, drug discovery organizations, pharmaceutical companies and research institutions is indispensable. It takes place once a year in Seoul and mainly focuses on biotechnology and its related fields. Here, companies and organizations in the development and research of new methods of treatment using biotechnological methods or made from living organisms and derived from them are represented. Together with CPhI Korea, P-MEC Korea and ICSE Korea it is the largest pharmaceutical exhibition in the Corean area. They represent and reflect the entire supply and process chain of the pharmaceutical industry and ensure tremendous synergies.

The BioLive will take place on 3 days from Wednesday, 28. September to Friday, 30. September 2022 in Seoul.